• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    NeoGenomics, Inc. - Common Stock (NQ:NEO)

    11.27 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Feb 5, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 188
    Open 11.27
    Bid (Size) 11.00 (200)
    Ask (Size) 12.85 (100)
    Prev. Close 11.27
    Today's Range 11.27 - 11.27
    52wk Range 4.720 - 14.73
    Shares Outstanding 122,816,314
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
    From NeoGenomics, Inc.
    Via Business Wire
    News headline image
    3 Cash-Burning Stocks with Warning Signs
    Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable. 
    Via StockStory
    Topics Electric Vehicles

    Performance

    YTD
    -4.2%
    -4.2%
    1 Month
    -12.0%
    -12.0%
    3 Month
    +8.4%
    +8.4%
    6 Month
    +95.7%
    +95.7%
    1 Year
    -20.0%
    -20.0%

    More News

    Read More
    News headline image
    NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
    From NeoGenomics, Inc.
    Via Business Wire
    News headline image
    NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
    From NeoGenomics, Inc.
    Via Business Wire
    News headline image
    NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors
    From NeoGenomics, Inc.
    Via Business Wire
    News headline image
    3 Russell 2000 Stocks We Think Twice About
    Via StockStory
    News headline image
    3 Stocks Under $50 We Steer Clear Of
    Via StockStory
    News headline image
    NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
    From NeoGenomics, Inc.
    Via Business Wire
    News headline image
    NeoGenomics to Present New ctDNA Research at SABCS 2025
    From NeoGenomics, Inc.
    Via Business Wire
    News headline image
    NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025
    From NeoGenomics, Inc.
    Via Business Wire
    News headline image
    Testing & Diagnostics Services Stocks Q3 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)
    Via StockStory
    News headline image
    3 Overrated Stocks That Concern Us
    Via StockStory
    News headline image
    1 Cash-Burning Stock to Research Further and 2 We Brush Off
    Via StockStory
    Topics Retirement
    News headline image
    NeoGenomics, Fortrea, and Acadia Healthcare Shares Skyrocket, What You Need To Know
    Via StockStory
    Topics Artificial Intelligence Economy Stocks
    News headline image
    1 High-Flying Stock on Our Buy List and 2 We Find Risky
    Via StockStory
    News headline image
    Earnings Scheduled For November 14, 2025 ↗
    Via Benzinga
    News headline image
    1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off
    Via StockStory
    News headline image
    3 Volatile Stocks We Keep Off Our Radar
    Via StockStory
    News headline image
    NeoGenomics to Participate in Upcoming Investor Conferences
    From NeoGenomics, Inc.
    Via Business Wire
    News headline image
    The Top 5 Analyst Questions From NeoGenomics’s Q3 Earnings Call
    Via StockStory
    Topics Earnings
    News headline image
    NeoGenomics (NEO): Buy, Sell, or Hold Post Q3 Earnings?
    Via StockStory
    Topics Stocks
    News headline image
    NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
    From NeoGenomics, Inc.
    Via Business Wire
    News headline image
    NEO Q3 Deep Dive: Clinical Volume Gains and New Product Launches Shape Outlook
    Via StockStory
    News headline image
    NeoGenomics (NEO) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings Intellectual Property
    News headline image
    Why NeoGenomics (NEO) Stock Is Trading Up Today
    Via StockStory
    Topics World Trade

    Frequently Asked Questions

    Is NeoGenomics, Inc. - Common Stock publicly traded?
    Yes, NeoGenomics, Inc. - Common Stock is publicly traded.
    What exchange does NeoGenomics, Inc. - Common Stock trade on?
    NeoGenomics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for NeoGenomics, Inc. - Common Stock?
    The ticker symbol for NeoGenomics, Inc. - Common Stock is NEO on the Nasdaq Stock Market
    What is the current price of NeoGenomics, Inc. - Common Stock?
    The current price of NeoGenomics, Inc. - Common Stock is 11.27
    When was NeoGenomics, Inc. - Common Stock last traded?
    The last trade of NeoGenomics, Inc. - Common Stock was at 02/05/26 04:00 PM ET
    What is the market capitalization of NeoGenomics, Inc. - Common Stock?
    The market capitalization of NeoGenomics, Inc. - Common Stock is 1.38B
    How many shares of NeoGenomics, Inc. - Common Stock are outstanding?
    NeoGenomics, Inc. - Common Stock has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.